TVRD
Tvardi Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+3.24%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-310.9%
Return on equity
-148.8%
Return on assets
-319.0%
Return on invested capital
0.00x
Asset turnover
-$25.0M
Cash from operations
$1.18
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026